- Markets
- Trading
- ENTERO
ENTERO
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Entero Healthcare Solutions Says Chebolu Venkataramana Ram Resigns As CFO
March 21 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
ENTERO HEALTHCARE SOLUTIONS - CHEBOLU VENKATARAMANA RAM RESIGNS FROM THE POSITION OF CFO
ENTERO HEALTHCARE SOLUTIONS - APPOINTS BALAKRISHNAN NATESAN KAUSHIK AS CFO
Source text: [ID:]
Further company coverage: ENTE.NS
(([email protected];;))
March 21 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
ENTERO HEALTHCARE SOLUTIONS - CHEBOLU VENKATARAMANA RAM RESIGNS FROM THE POSITION OF CFO
ENTERO HEALTHCARE SOLUTIONS - APPOINTS BALAKRISHNAN NATESAN KAUSHIK AS CFO
Source text: [ID:]
Further company coverage: ENTE.NS
(([email protected];;))
Entero Healthcare Solutions Acquires Aayu Chemist App, Medcords Platform From Medcords Healthcare
March 19 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
ENTERO HEALTHCARE SOLUTIONS - ACQUIRED AAYU CHEMIST APP, MEDCORDS PLATFORM FROM MEDCORDS HEALTHCARE
Source text: [ID:]
Further company coverage: ENTE.NS
(([email protected];))
March 19 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
ENTERO HEALTHCARE SOLUTIONS - ACQUIRED AAYU CHEMIST APP, MEDCORDS PLATFORM FROM MEDCORDS HEALTHCARE
Source text: [ID:]
Further company coverage: ENTE.NS
(([email protected];))
Entero Healthcare Solutions Invests 170 Mln Rupees In Getwell Medicare Shares
March 6 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
INVESTS 170 MILLION RUPEES IN GETWELL MEDICARE SHARES
Source text: ID:nBSE8gb56S
Further company coverage: ENTE.NS
(([email protected];;))
March 6 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
INVESTS 170 MILLION RUPEES IN GETWELL MEDICARE SHARES
Source text: ID:nBSE8gb56S
Further company coverage: ENTE.NS
(([email protected];;))
India's Entero Healthcare hits record high after upbeat Q1 results
** Shares of Entero Healthcare Solutions Ltd ENTE.NS rise as much as 6.6% to record 1,320.90 rupees
** Healthcare products distributor crosses IPO issue price of 1,258 rupees for the first time
** Stock last up 4.3%
** ENTE after market hours on Friday reported over 3x jump in Q1 profit
** Jefferies maintains "buy", says it likes ENTE's guidance of at least 35% rev growth in FY25
** Brokerage keeps 1,510 rupees PT unchanged, sees ENTE's profit after tax rising ~7x by FY26
** Around 139,000 shares traded, 2.8x 30-day avg volume
(Reporting by Nandan Mandayam in Bengaluru)
(([email protected]; Mobile: +91 9591011727;))
** Shares of Entero Healthcare Solutions Ltd ENTE.NS rise as much as 6.6% to record 1,320.90 rupees
** Healthcare products distributor crosses IPO issue price of 1,258 rupees for the first time
** Stock last up 4.3%
** ENTE after market hours on Friday reported over 3x jump in Q1 profit
** Jefferies maintains "buy", says it likes ENTE's guidance of at least 35% rev growth in FY25
** Brokerage keeps 1,510 rupees PT unchanged, sees ENTE's profit after tax rising ~7x by FY26
** Around 139,000 shares traded, 2.8x 30-day avg volume
(Reporting by Nandan Mandayam in Bengaluru)
(([email protected]; Mobile: +91 9591011727;))
Entero Healthcare Solutions To Buy Gourav Medical Agencies, Sai Pharma Distributor, Srinivasa Lifecare
Aug 2 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
TO BUY GOURAV MEDICAL AGENCIES, SAI PHARMA DISTRIBUTOR, SRINIVASA LIFECARE
Source text for Eikon: [ID:]
Further company coverage: ENTE.NS
(([email protected];))
Aug 2 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
TO BUY GOURAV MEDICAL AGENCIES, SAI PHARMA DISTRIBUTOR, SRINIVASA LIFECARE
Source text for Eikon: [ID:]
Further company coverage: ENTE.NS
(([email protected];))
Entero Healthcare Solutions To Execute Definitive Agreements To Acquire 100% Stake In Devi Pharma Wellness
June 28 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
ENTERO HEALTHCARE SOLUTIONS LTD - TO EXECUTE DEFINITIVE AGREEMENTS TO ACQUIRE 100% PAID-UP EQUITY SHARE CAPITAL OF DEVI PHARMA WELLNESS
Source text for Eikon: ID:nNSE14BXwn
Further company coverage: ENTE.NS
(([email protected];;))
June 28 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
ENTERO HEALTHCARE SOLUTIONS LTD - TO EXECUTE DEFINITIVE AGREEMENTS TO ACQUIRE 100% PAID-UP EQUITY SHARE CAPITAL OF DEVI PHARMA WELLNESS
Source text for Eikon: ID:nNSE14BXwn
Further company coverage: ENTE.NS
(([email protected];;))
Entero Healthcare Solutions To Acquire 80% Share Capital Of Avenir Lifecare Pharma
May 6 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
TO EXECUTE DEFINITIVE AGREEMENTS TO ACQUIRE 80% PAID- UP SHARE CAPITAL OF AVENIR LIFECARE PHARMA
Source text for Eikon: ID:nBSE8BKDg2
Further company coverage: ENTE.NS
(([email protected];;))
May 6 (Reuters) - Entero Healthcare Solutions Ltd ENTE.NS:
TO EXECUTE DEFINITIVE AGREEMENTS TO ACQUIRE 80% PAID- UP SHARE CAPITAL OF AVENIR LIFECARE PHARMA
Source text for Eikon: ID:nBSE8BKDg2
Further company coverage: ENTE.NS
(([email protected];;))
India's Entero Healthcare jumps as Investec initiates with 'buy'
** Shares of Entero Healthcare Ltd ENTE.NS up 5% at 1,201.10 rupees
** Investec begins coverage of healthcare products distributor with "buy" rating, PT of 1,590 rupees
** Brokerage says ENTE's "attractive" acquisitions power inorganic growth, complement organic growth and are "margin-accretive, creating shareholders' value from day 1"
** Sees EBITDA margin growing to 4.5% by FY26 from 3% in FY24 as it builds scale and reduces dependence on top customer Apollo group
** ENTE trades at ~30% discount to pharmacy retailer Medplus Health Services Ltd MEDP.NS due to business-to-business model but could narrow the gap on higher growth in long-term and better returns - Investec
** Earlier this month, Jefferies also initiated stock with "buy"
** Around 166,000 shares traded, 1.2x 30-day avg volume
** Stock down 2.3% since listing in mid-Feb, while MEDP has gained ~1.5% in the same period
(Reporting by Nandan Mandayam in Bengaluru)
(([email protected]; Mobile: +91 9591011727;))
** Shares of Entero Healthcare Ltd ENTE.NS up 5% at 1,201.10 rupees
** Investec begins coverage of healthcare products distributor with "buy" rating, PT of 1,590 rupees
** Brokerage says ENTE's "attractive" acquisitions power inorganic growth, complement organic growth and are "margin-accretive, creating shareholders' value from day 1"
** Sees EBITDA margin growing to 4.5% by FY26 from 3% in FY24 as it builds scale and reduces dependence on top customer Apollo group
** ENTE trades at ~30% discount to pharmacy retailer Medplus Health Services Ltd MEDP.NS due to business-to-business model but could narrow the gap on higher growth in long-term and better returns - Investec
** Earlier this month, Jefferies also initiated stock with "buy"
** Around 166,000 shares traded, 1.2x 30-day avg volume
** Stock down 2.3% since listing in mid-Feb, while MEDP has gained ~1.5% in the same period
(Reporting by Nandan Mandayam in Bengaluru)
(([email protected]; Mobile: +91 9591011727;))
India's Entero Healthcare surges as Jefferies initiates with 50% upside view
** Shares of healthcare products distributor Entero Healthcare Solutions ENTE.NS up 20% at 1,202.30
** Stock hits upper limit of exchange-mandated trading band
** Jefferies initiates stock with "buy" and PT of 1,510 rupees, a 50% upside from Wednesday's close of 1,001.95 rupees
** ENTE is well-placed to grow 20% organically in FY24-26, brokerage says
** Jefferies expects 44% revenue CAGR at 80 bln rupees ($959.4 mln) for co over FY24-26
** It sees EBITDA margins rising to 4.8% by FY26 from 2.9% in FY24
** ENTE down about 20% from its debut in Feb, as of last close
($1 = 83.3870 Indian rupees)
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
** Shares of healthcare products distributor Entero Healthcare Solutions ENTE.NS up 20% at 1,202.30
** Stock hits upper limit of exchange-mandated trading band
** Jefferies initiates stock with "buy" and PT of 1,510 rupees, a 50% upside from Wednesday's close of 1,001.95 rupees
** ENTE is well-placed to grow 20% organically in FY24-26, brokerage says
** Jefferies expects 44% revenue CAGR at 80 bln rupees ($959.4 mln) for co over FY24-26
** It sees EBITDA margins rising to 4.8% by FY26 from 2.9% in FY24
** ENTE down about 20% from its debut in Feb, as of last close
($1 = 83.3870 Indian rupees)
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
India's Entero Healthcare falls in debut trade
** Shares of Entero Healthcare Solutions ENTE.NS down 4.1% at 1,207.55 rupees after listing on Friday
** Healthcare products distributor trading below issue price of 1,258 rupees
** Fall in shares "highlighted certain concerns surrounding the company's financial health" - Shivani Nyati, head of wealth at Swastika Investmart
** Over 1 mln shares traded
** IPO had fresh issue of shares worth 10 bln rupees, offer for sale of shares worth 6 billion rupees
(Reporting by Nandan Mandayam in Bengaluru)
(([email protected]; Mobile: +91 9591011727;))
** Shares of Entero Healthcare Solutions ENTE.NS down 4.1% at 1,207.55 rupees after listing on Friday
** Healthcare products distributor trading below issue price of 1,258 rupees
** Fall in shares "highlighted certain concerns surrounding the company's financial health" - Shivani Nyati, head of wealth at Swastika Investmart
** Over 1 mln shares traded
** IPO had fresh issue of shares worth 10 bln rupees, offer for sale of shares worth 6 billion rupees
(Reporting by Nandan Mandayam in Bengaluru)
(([email protected]; Mobile: +91 9591011727;))
Events:
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Entero Healthcare do?
Entero Healthcare Solutions Limited is one of India's largest and fastest growing healthcare products distribution platforms. The company offers both demand generation and demand fulfilment solutions to healthcare product manufacturers. It offers demand generation solutions to healthcare product manufacturers by promoting and creating awareness of their product brands to healthcare professionals, doctors and channels such as pharmacies, hospitals (both private and government), clinics and customers through e-commerce marketplaces. Further, it provides end-to-end healthcare products distribution solutions including imports, central warehousing, redistribution, last mile delivery and connection with the pharmacies, hospitals and clinics.
Who are the competitors of Entero Healthcare?
Entero Healthcare major competitors are Royal Sense, Jeena Sikho Life, Elitecon Internation, Lloyds Enterprises, Optiemus Infracom, Honasa Consumer, SG Mart. Market Cap of Entero Healthcare is ₹6,018 Crs. While the median market cap of its peers are ₹5,095 Crs.
Is Entero Healthcare financially stable compared to its competitors?
Entero Healthcare seems to be less financially stable compared to its competitors. Altman Z score of Entero Healthcare is 8.73 and is ranked 6 out of its 8 competitors.
Does Entero Healthcare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Entero Healthcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Entero Healthcare allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Entero Healthcare balance sheet?
Balance sheet of Entero Healthcare is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Entero Healthcare improving?
Yes, profit is increasing. The profit of Entero Healthcare is ₹97.19 Crs for TTM, ₹39.11 Crs for Mar 2024 and -₹11.56 Crs for Mar 2023.
Is the debt of Entero Healthcare increasing or decreasing?
Yes, The debt of Entero Healthcare is increasing. Latest debt of Entero Healthcare is -₹177.75 Crs as of Sep-24. This is greater than Mar-24 when it was -₹1,507.51 Crs.
Is Entero Healthcare stock expensive?
Entero Healthcare is not expensive. Latest PE of Entero Healthcare is 66.79, while 3 year average PE is 82.1. Also latest EV/EBITDA of Entero Healthcare is 38.55 while 3yr average is 45.42.
Has the share price of Entero Healthcare grown faster than its competition?
Entero Healthcare has given lower returns compared to its competitors. Entero Healthcare has grown at ~21.71% over the last 1yrs while peers have grown at a median rate of 80.45%
Is the promoter bullish about Entero Healthcare?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Entero Healthcare is 52.42% and last quarter promoter holding is 52.44%
Are mutual funds buying/selling Entero Healthcare?
The mutual fund holding of Entero Healthcare is increasing. The current mutual fund holding in Entero Healthcare is 6.09% while previous quarter holding is 5.29%.